Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Written by Daniel Cohen and Scott Matusow Karuna Therapeutics (KRTX), NextCure (NXTC), and Constellation Pharmaceuticals (CNST) are but the latest examples of how the biotech sector has been heating up. All 3 of these names have seen very strong stock appreciation on earl...
LEXINGTON, Mass. , Nov. 26, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, Chief Executive Officer of Curis, will present at the 31 st Ann...
LEXINGTON, Mass. , Nov. 6, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that abstracts for both fimepinostat and CA-4948 were accepted for presentation at the 61 ...
Curis, Inc. (CRIS) Q3 2019 Results Earnings Conference Call November 05, 2019, 04:30 PM ET Company Participants Bill Steinkrauss - Chief Financial Officer James Dentzer - President and Chief Executive Officer Robert Martell - Research & Development Conference Call Particip...
The following slide deck was published by Curis, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Gainers : NextCure (NASDAQ: NXTC ) +183% . Fulgent Genetics (NASDAQ: FLGT ) +35% . NIO (NYSE: NIO ) +28% . Acorda Therapeutics (NASDAQ: ACOR ) +26% . EverQuote (NASDAQ: EVER ) +27% . Forterra (NASDAQ: FRTA ) +25% . Gaia (NASDAQ: GAIA ) +23% . Agile Therapeutics (NASDAQ: AGRX ) +23%...
Curis (NASDAQ: CRIS ): Q3 GAAP EPS of -$0.19. More news on: Curis, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
LEXINGTON, Mass. , Nov. 5, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the third quarter ended September 30, 2019. ...
LEXINGTON, Mass. , Oct. 29, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its third quarter financial results on Tuesday, Novem...
News, Short Squeeze, Breakout and More Instantly...
2024-07-15 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass. , July 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IR...
2024-05-25 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...